Oh dear, the good the bad and the ugly foot in mouth, or cunning to stone wall the FDA as a cure for the common cold
"In individuals where there is compromised lung function, what is a minor virus to the rest of the community is of severe and indeed even fatal consequence,'' Mr Cook said. He said the drug would not be economically viable for otherwise healthy patients with common colds that did not warrant treatment.
Shares in the company closed up 7¢ at 93¢"
Read more: http://www.theage.com.au/business/biota-cold-drug-test-20120328-1vypk.html#ixzz1qQCpj8aq
- Forums
- ASX - By Stock
- newspaper article at last
Oh dear, the good the bad and the ugly foot in mouth, or cunning...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online